CE

Celanese Corp. 10-Q Summary: Quarter Ended September 30, 2005

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended September 30, 2005, for Celanese Corporation (the "Successor"), a global industrial chemicals company. The financial statements reflect the acquisition of Celanese AG ("CAG" or the "Predecessor") in April 2004 using the purchase method of accounting. As of November 2, 2005, Celanese owned approximately 98% of CAG shares and initiated a squeeze-out process for remaining minority shareholders. The company operates through four primary segments: Chemical Products, Technical Polymers (Ticona), Acetate Products, and Performance Products.

Key Financial Metrics

Note: Q3 2004 and YTD 2004 data are presented for the Successor where available; otherwise, Predecessor data is noted in the text. Net Debt is a non-GAAP measure defined as Total Debt less Cash and Cash Equivalents.

Material Changes vs. Prior Period

• Revenue Growth: Net sales increased 21% in Q3 2005 compared to Q3 2004, driven by a 9% price increase (primarily in Chemical Products) and an 11% contribution from recent acquisitions (Vinamul and Acetex). This offset a 1% volume decline.
• Profitability: Operating profit more than tripled to $92 million from $25 million. This was driven by higher pricing, productivity improvements, and a $35 million reduction in special charges. These gains offset higher raw material and energy costs.
• Special Charges: Special charges decreased to $24 million in Q3 2005 from $59 million in Q3 2004. The 2004 period included significant impairment charges related to the Acetate Products restructuring. Q3 2005 charges included $12 million for environmental remediation strategy changes at the Edmonton methanol plant and severance costs.
• Acquisitions: The company acquired Vinamul (February 2005) and Acetex (July 2005). Acetex contributed $115 million in sales for the nine months ended September 30, 2005, but recorded an operating loss of $1 million due to integration costs and purchase accounting adjustments.
• Interest Expense: Interest expense decreased $26 million to $72 million in Q3 2005 compared to Q3 2004, primarily due to the absence of $39 million in refinancing costs (deferred financing costs and prepayment premiums) incurred in 2004. This was partially offset by higher debt levels and interest rates in 2005.

Guidance, Outlook, Risks, and Unusual Items

• Outlook: Management expects North American and Asian markets to continue growing in Q4 2005. However, pricing may be temporarily impacted by new acetyls capacity coming online. The company anticipates continued expenses for restructuring and portfolio optimization.
• Dividends: The company adopted a dividend policy in July 2005, paying $0.16 per share annually on Series A common stock. The first quarterly payment was made in August 2005. Preferred stock dividends of 4.25% per annum are also being paid.
• Legal Proceedings:
  • Plumbing Actions: Remaining accruals are $68 million. Management believes provisions are adequate.
  • Sorbates Antitrust: Remaining accruals are $130 million, with a potential additional loss range of $0 to $9 million. The company has a receivable of $104 million from Hoechst for indemnification.
  • Patent Infringement: A Taiwanese court awarded Celanese approximately $28 million for acetic acid patent infringement; the judgment is under appeal and income will not be recorded until cash is received.
• Internal Controls: The company identified material weaknesses in internal controls over financial reporting related to complex accounting matters and hedge documentation. A significant deficiency regarding sales to sanctioned countries was also identified. Management expects to remediate these issues by the end of fiscal year 2005.
• Hurricane Rita: The company expects an aggregate negative impact on earnings of approximately $15 million in Q3 and Q4 2005 due to the hurricane, though plant damage was minimal.

Investor Verification Checklist

• Debt Service Capacity: Verify the company's ability to service $3.5 billion in total debt given the high leverage and significant contractual obligations, particularly the Domination Agreement requirements to compensate CAG for statutory losses.
• Acquisition Integration: Monitor the integration progress and profitability of the Vinamul and Acetex acquisitions, which currently show operating losses due to purchase accounting adjustments and integration costs.
• Legal Reserves: Confirm the adequacy of reserves for the Sorbates antitrust matter ($130 million) and Plumbing actions ($68 million), and track the status of the Hoechst indemnification receivable.
• Internal Control Remediation: Assess the timeline and effectiveness of remediation plans for the identified material weaknesses in internal controls and the significant deficiency regarding export controls.
• Raw Material Costs: Evaluate the impact of rising ethylene and natural gas prices on margins, particularly in downstream products like emulsions and polyvinyl alcohol where margin compression was noted.